bpc 157 ben greenfield Repost @peptides with @use.repost ・・・ BREAKING NEWS! Today's 8–6 advisory vote for BPC-157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents Peptides: Little Proteins, Big Impacts

Theoretical and reported concerns Off-target cell death: no compound is perfectly selective, so healthy cells with temporarily high FOXO4 could be affected in theory

Serum N(1)-methylnicotinamide is associated with obesity and diabetes in Chinese (in Eng)

[DOI] [PMC free article] [PubMed] [Google Scholar] 898

No established human half-life was identified

While oral delivery subjects peptides to digestive enzymes, KPV is a remarkably small molecule, just three amino acids, which appears to give it better oral bioavailability than larger peptides

Commercial involvement does not invalidate the data, but it is relevant when assessing independence and the need for replication